openPR Logo
Press release

The Intravitreal IVT Injectable Market to Gloat Over Advancement in Healthcare Marketing Technology

02-15-2022 02:57 AM CET | Health & Medicine

Press release from: Persistence Market Research

The Intravitreal IVT Injectable Market to Gloat Over

The Intravitreal IVT Injectable Market is likely to grow stupendously in the subsequent decade. With IoT in the picture, the complex medical equipment could be monitored, that too, all at a time and under one umbrella. As such, costly downtime could be avoided and predictive maintenance could be fostered. Plus, increased spending could be facilitated for disposable items like syringes, gloves, and masks.

Get Sample Copy of this Report@ https://www.persistencemarketresearch.com/samples/25906

Retinal diseases contributing heavily to the demand growth of intravitreal (IVT) injectables

Hereditary retinal diseases is the major cause of visual loss. Macular degeneration, Diabetic Retinopathy is the important and prominent cause of blindness. According to Genentech Retinal disease report, around 11 million US population are affected with age-related macular degeneration, 7.7 million people are affected with diabetic retinopathy and around 1.1 million population are affected with retinal vein occlusions.

Anti-VEGF intravitreal (IVT) injectables medication is most likely use to treat retinal disorders. Increasing prescription of anti-VEGF anticipate the growth of the intravitreal (IVT) injectables market. Many manufacturers aims to develop drugs with anti-VEGF inhibitor, as a result leading to an increase in the demand for intravitreal (IVT) injectables.

Company Profiles:

Regeneron Pharmaceuticals, Inc.
Bausch & Lomb
Novartis AG
Allergan
Alimera Sciences
ThromboGenics, Inc.
Bristol-Myers Squibb Company
Other

Request for Methodology@ https://www.persistencemarketresearch.com/methodology/25906

North America to have substantial revenue growth in intravitreal (IVT) injectables Market

North America region shown to have high growth in intravitreal (IVT) injectables market. Low vision and blindness are prevailing in the region and high prescription of anti-VEGF intravitreal (IVT) injectables medication has increases the growth of intravitreal (IVT) injectables market. It is estimated that intravitreal (IVT) injectables create an incremental $ opportunity worth US$ 4,350 Mn between 2018 and 2028.

Lucentis marketed by Roche and Eylea marketed by Regeneron in the United States, are the commonly prescribed biologics use in intravitreal (IVT) injectables. Apart from this, Avastin and Macugen are also widely used in intravitreal (IVT) injectables market. The North America region holds a significant share in intravitreal (IVT) injectables among all other regions, due to the increase in prescription of retinal biologics, high healthcare facilities and availability and usage of expensive drugs.

Access Full Report@ https://www.persistencemarketresearch.com/checkout/25906

Intravitreal (IVT) Injectables Market: Segmental Analysis

The global intravitreal (IVT) injectables market has been segmented on the basis of drug class, indication and distributional channel. On the basis of drug class, the intravitreal (IVT) injectables market has been segmented into anti-VEGF, corticosteroids, antibiotics, antivirals and antifungals. Based on indication, the intravitreal (IVT) injectables market has been segmented into diabetic retinopathy, macular degeneration, endophthalmitis, retinal vein occlusions and others.

Complete Report Details@ https://www.persistencemarketresearch.com/market-research/intravitreal-ivt-injectable-market.asp

In terms of revenue, the anti-VEGF segment is expected to have a major share in intravitreal (IVT) injectables during the forecast period as it prevents angiogenesis and also minimize the leakage of fluid that occurs due to retinal diseases. On the basis of distributional channel, the intravitreal (IVT) injectables market has been categorized into hospital pharmacies, retail pharmacies, drug stores, mail order pharmacies and others. The hospital pharmacies is expected to have high revenue growth in intravitreal (IVT) injectables, owing to the availability of biologics and increase in prescription of anti-VEGF drugs.

Related Reports:

Sterile Injectable Drugs Market - https://www.persistencemarketresearch.com/market-research/sterile-injectable-drugs-market.asp

U.S Bacterial Conjunctivitis Drugs Market - https://www.persistencemarketresearch.com/market-research/u.s-bacterial-conjunctivitis-drugs-market.asp

Contact Us:

Persistence Market Research
Address – 305 Broadway, 7th Floor, New York City, NY 10007 United States
U.S. Ph. – +1-646-568-7751
USA-Canada Toll-free – +1 800-961-0353
Sales – sales@persistencemarketresearch.com
Website – https://www.persistencemarketresearch.com

About Us:

Persistence Market Research is here to provide companies a one-stop solution with regards to bettering customer experience. It does engage in gathering appropriate feedback after getting through personalized customer interactions for adding value to customers’ experience by acting as the “missing” link between “customer relationships” and “business outcomes’. The best possible returns are assured therein.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release The Intravitreal IVT Injectable Market to Gloat Over Advancement in Healthcare Marketing Technology here

News-ID: 2552392 • Views:

More Releases from Persistence Market Research

Plug-in Hybrid Electric Vehicles Market to Reach US$ 98.5 Billion by 2031
Plug-in Hybrid Electric Vehicles Market to Reach US$ 98.5 Billion by 2031
Introduction The global plug-in hybrid electric vehicles (PHEVs) market has been on an upward trajectory, driven by a growing emphasis on environmental sustainability and advancements in automotive technology. As governments and regulatory bodies push for cleaner alternatives to conventional vehicles, PHEVs have gained traction as a viable transitional technology in the shift toward fully electric mobility. This report explores key market drivers, challenges, trends, technological advancements, and regional dynamics that shape
Forklift Trucks Market Projected to Hit US$ 89.4 Billion by 2031
Forklift Trucks Market Projected to Hit US$ 89.4 Billion by 2031
Introduction The global forklift trucks market has become increasingly critical as industries strive to improve productivity, efficiency, and safety in material handling. The rising demand across sectors like manufacturing, construction, retail, and warehousing has propelled growth in the forklift industry, leading to technological advancements and the development of more sustainable and efficient machinery. This report provides an in-depth analysis of the forklift trucks market, focusing on market trends, key drivers, regional
North America Micro Market Set to Reach US$23.9 Billion by 2031, Driven by Convenience and Technological Advancements
North America Micro Market Set to Reach US$23.9 Billion by 2031, Driven by Conve …
The North America micro market is poised for significant growth, with an estimated valuation of US$23.9 billion by 2031, reflecting a robust compound annual growth rate (CAGR) of 10.2% during the forecast period from 2024 to 2031. This growth is driven by the increasing demand for convenience and the integration of cutting-edge technologies in retail experiences. Request a sample report@ https://www.persistencemarketresearch.com/samples/34675 Market Overview The North America micro market, which encompasses self-service retail spaces
Aircraft Engines Market Expected to Surpass US$ 141.35 Million by 2031
Aircraft Engines Market Expected to Surpass US$ 141.35 Million by 2031
Introduction The global aircraft engines market is experiencing substantial growth, driven by an increase in air travel demand, continuous technological advancements, and regulatory requirements focused on fuel efficiency and emission reduction. Aircraft engines, the core of aviation operations, are pivotal in ensuring safe and efficient air travel. As airline companies and manufacturers look to meet evolving demands, innovations in aircraft engine design, materials, and fuel efficiency are leading the market's expansion. This

All 5 Releases


More Releases for IVT

The Intravitreal (IVT) Injectable Market To Prove Its Servility To Technological …
According to the most recent Persistence Market Research (PMR) report, the Intravitreal (IVT) Injectables Market will grow at a CAGR of 4.9% between 2022 and 2028, surpassing US$ 23,814.3 million in terms of market value. Growing retinal diseases are expected to boost the global intravitreal injectable market at a substantial rate over the forecast period. Millions of people are affected by retinal disorders, which commonly result in vision loss or complete
Consumer-Facing Telemedicine To Drive The Intravitreal (IVT) Injectable Market, …
The Intravitreal Ivt Injectable Market is bound to reach US$ 23,814.3 Mn at a CAGR of 4.9% between 2018-2028. The current scenario is such that on-demand healthcare storage is being asked for. Cloud computing thus curtails operational expenses and capital as it simplifies sharing medical records, creates and maintains telehealth apps, and automates backend operations. This would be the scene with the healthcare vertical in the upcoming period. According to the
The Intravitreal IVT Injectable Market to Witness Invigorating Trends
The Intravitreal IVT Injectable Market is expected to grow on an irreversible note in the next 10 years. The future scenario would be data-driven healthcare. This would, in turn, widen the potential for enhancing treatment options. With interoperability taking the centre stage, program participants could access app blueprints, data templates, and security tools. Thus, the big data cloud would turn out to be kinetic. This would result in an upswing
The Intravitreal IVT Injectable Market to grow on an invincible note
The Intravitreal IVT Injectable Market is expected to grow by leaps and bounds in the forecast period. Nanotechnology’s medical application is on the anvil. As such, nanomedicine is an outcome of the technology operating at the molecular, atomic, or supramolecular scale. The broad application areas of nanomedicine include sensing, imaging, diagnosis, and delivery via medical devices. This would certainly keep the healthcare vertical upgraded continuously. Hereditary retinal diseases is the major
Global Intravitreal (IVT) Injectables Market : Rising Allocations On analysis  …
Albany, NY, 18th April : Recent research and the current scenario as well as future market potential of "Global Market Study on Intravitreal (IVT) Injectables: Chronic Retinal Conditions to Uplift Sales of Anti-VEGF IVT Injectables" globally. Recently published report titled ‘Intravitreal (IVT) Injectables Market: Global Industry Analysis 2013 – 2017 and Forecast 2018–2028' offers a comprehensive assessment of the key dynamics pertaining to the intravitreal (IVT) injectables market. The report presents
Isabellenhüttes IVT-S measures current in the Fraunhofer development platform f …
The Fraunhofer Institute for Integrated Systems and Device Technology (IISB), Erlangen, is using Isabellenhütte’s shunt-based management system IVT-S for precision current measurement in battery management systems in its foxBMS development platform. The Isabellenhütte IVT series offers precise, temperature-compensated current and voltage measurement in a single component. Isabellenhütte's IVT systems are mainly used in the rapidly growing market for lithium-ion traction batteries and can be found in electric cars, electric trucks, electric